Projects per year
Fingerprint Dive into the research topics where James D Lechleiter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Oocytes
Medicine & Life Sciences
Xenopus
Medicine & Life Sciences
Astrocytes
Medicine & Life Sciences
Calcium Signaling
Medicine & Life Sciences
Mitochondria
Medicine & Life Sciences
Xenopus laevis
Medicine & Life Sciences
Confocal Microscopy
Medicine & Life Sciences
Calcium
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1985 2020
San Antonio Biomedical Education and Research
Lechleiter, J. D., McManus, L. M., Mcmanus, L. M. & Oyajobi, B.
7/1/15 → 3/31/20
Project: Research project
education
health science
pedagogics
science
trainee
Regulation of ER-stress Activated UPR kinase PERK in Neurodegenerative Diseases
Project: Research project
ASTROCYTE ACTIVATION BY SMALL MOLECULE P2Y1 AGONISTS FOR TREATMENT OF TBI
9/30/15 → 6/30/17
Project: Research project
Astrocytes
Emergency Responders
Pharmaceutical Preparations
Therapeutic Human Experimentation
Therapeutics
Research Output 1984 2019
1
Citation
(Scopus)
Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K+ currents in neurons
Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M. A., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., M Carver, C., Cavazos, J. E., Brenner, R., Lechleiter, J. D. & Shapiro, M. S., Jan 1 2019, In : Journal of Cerebral Blood Flow and Metabolism.Research output: Contribution to journal › Article
Pharmacology
Neurons
Brain
Physiological Stress
Seizures
Time to Target Stroke: Examining the Circadian System in Stroke
Stubblefield, J. J. & Lechleiter, J. D., Jun 1 2019, In : The Yale journal of biology and medicine. 92, 2, p. 349-357 9 p.Research output: Contribution to journal › Review article
Stroke
Blood
Astrocytes
Neurons
Clocks
14
Citations
(Scopus)
Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment
Van Skike, C. E., Jahrling, J. B., Olson, A. B., Sayre, N. L., Hussong, S. A., Ungvari, Z., Lechleiter, J. D. & Galvan Hart, V., Apr 1 2018, In : American Journal of Physiology - Heart and Circulatory Physiology. 314, 4, p. H693-H703Research output: Contribution to journal › Article
Sirolimus
Blood-Brain Barrier
Blood Vessels
Alzheimer Disease
LDL Receptors
1
Citation
(Scopus)
The long-term effect of maternal dietary protein restriction on 5-HT1A receptor function and behavioral responses to stress in adulthood
Ye, W., Pitlock, M. D., Javors, M. A., Thompson, B. J., Lechleiter, J. D. & Hensler, J. G., Jan 1 2018, (Accepted/In press) In : Behavioural Brain Research.Research output: Contribution to journal › Article
Protein-Restricted Diet
Receptor, Serotonin, 5-HT1A
Dietary Proteins
Mothers
Psychiatry
6
Citations
(Scopus)
Cyclophilin D over-expression increases mitochondrial complex III activity and accelerates supercomplex formation
Etzler, J. C., Bollo, M., Holstein, D., Deng, J. J., Perez, V., Lin, D. T., Richardson, A., Bai, Y. & Lechleiter, J. D., Jan 1 2017, In : Archives of Biochemistry and Biophysics. 613, p. 61-68 8 p.Research output: Contribution to journal › Article
Electron Transport Complex III
Mitochondria
HEK293 Cells
Mitochondrial Proteins
Cells
Press/Media
Novel therapy administered after TBI prevents brain damage
Mark S Shapiro, Robert Brenner & James D Lechleiter
7/16/19 → 7/17/19
4 items of Media coverage
Press/Media: Press / Media
University of Texas Health Science Center-San Antonio: Novel Therapy Administered After TBI Prevents Brain Damage
Mark S Shapiro, Robert Brenner & James D Lechleiter
7/13/19
1 item of Media coverage
Press/Media: Press / Media
Global Neuroprotection Drugs Market is Expected
7/11/19
1 item of media coverage
Press/Media: Press / Media
Global Neuroprotection Drugs Market is Expected to Reach US$ 33,481.7 Million by 2027, Growing at an Estimated CAGR of 1.56% Over the Forecast Period, Says Absolute Markets Insights; Exclusive Research Report on Neuroprotection Drugs Market by Forecast 20
7/11/19
10 items of Media coverage
Press/Media: Press / Media
'Concussion Pill' Firm Likely to Get Fed Patent
11/6/15
1 item of media coverage
Press/Media: Press / Media